Istent Trabecular Micro-Bypass Stent System
Payments companies reported to CMS as associated with Istent Trabecular Micro-Bypass Stent System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Istent Trabecular Micro-Bypass Stent System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Istent Trabecular Micro-Bypass Stent System
These are the largest totals companies reported as associated with Istent Trabecular Micro-Bypass Stent System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Oluwatosin Smith | Dallas, TX | Ophthalmology | $126,275.00 |
| Iqbal Ahmed | Salt Lake City, UT | Ophthalmology | $63,187.50 |
| Sahar Bedrood | Pasadena, CA | Retina Specialist | $12,286.27 |
| Mark Gallardo | Las Cruces, NM | Ophthalmology | $7,005.96 |
| Arsham Sheybani | Saint Louis, MO | Glaucoma Specialist | $6,225.00 |
| Thomas Samuelson | Minnetonka, MN | Ophthalmology | $6,162.50 |
| Deborah Ristvedt | Alexandria, MN | Ophthalmology | $6,000.00 |
| Nathan Radcliffe | New York, NY | Ophthalmology | $5,870.74 |
| Arkadiy Yadgarov | Atlanta, GA | Glaucoma Specialist | $5,750.00 |
| Manjool Shah | Ann Arbor, MI | Ophthalmology | $4,875.00 |
Prescribed Istent Trabecular Micro-Bypass Stent System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.